Journal ArticleOPEN ACCESS

Exosome: A megastar of future cancer personalized and precision medicine

Clinical and Translational Discovery (2023) 3(3)
DOI: 10.1002/ctd2.208
29Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Extracellular vesicles (EVs) are an innovative orientation of next-generation cancer medicine. In EVs, the exosome is the most exciting domain associated with cancer research current decade.Exosomes have both cancer progression related and cancer healing capabilities depending on the source. It develops a new platform for cancer personalized and precision medicine visionary project to come to reality.

Author supplied keywords

Cite

CITATION STYLE

APA

Dhar, R., Gorai, S., Devi, A., Jha, S. K., Rahman, M. A., Alexiou, A., & Papadakis, M. (2023). Exosome: A megastar of future cancer personalized and precision medicine. Clinical and Translational Discovery, 3(3). https://doi.org/10.1002/ctd2.208

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free